|
ZSWIM6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.45410350427255E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.88659998523866E-09 |
| Normal-vs-Stage2 |
3.640300E-04 |
| Normal-vs-Stage3 |
9.85422854427043E-12 |
| Normal-vs-Stage4 |
1.06580000380774E-09 |
| Stage1-vs-Stage2 |
4.289000E-01 |
| Stage1-vs-Stage3 |
1.503670E-03 |
| Stage1-vs-Stage4 |
6.515200E-03 |
| Stage2-vs-Stage3 |
5.281200E-03 |
| Stage2-vs-Stage4 |
6.280800E-03 |
| Stage3-vs-Stage4 |
7.998000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.34460229009414E-11 |
| Normal-vs-AfricanAmerican |
4.741200E-03 |
| Normal-vs-Asian |
3.57650000000209E-05 |
| Caucasian-vs-AfricanAmerican |
2.092800E-01 |
| Caucasian-vs-Asian |
4.353600E-01 |
| AfricanAmerican-vs-Asian |
5.697800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.00979999309681E-09 |
| Normal-vs-Female |
9.28940258049238E-11 |
| Male-vs-Female |
8.514800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.86770000471159E-08 |
| Normal-vs-Age(41-60Yrs) |
3.65730001838926E-09 |
| Normal-vs-Age(61-80Yrs) |
1.88450033355991E-10 |
| Normal-vs-Age(81-100Yrs) |
3.244100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.589170E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.864400E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.573200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.319640E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.139000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.135400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.18520000036426E-07 |
| Classical-VS-Follicular |
1.862580E-01 |
| Classical-VS-Other |
7.741200E-01 |
| Classical-VS-Normal |
2.55240051316719E-10 |
| Tall-VS-Follicular |
2.34589999981161E-07 |
| Tall-VS-Other |
2.162200E-02 |
| Tall-VS-Normal |
1.72606373638473E-12 |
| Follicular-VS-Other |
5.073600E-01 |
| Follicular-VS-Normal |
1.554650E-04 |
| Other-VS-Normal |
1.415680E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.37029951222212E-10 |
| Normal-vs-N1 |
1.08300000001282E-06 |
| N0-vs-N1 |
7.558400E-01 |
|
|
